Tcr2 Therapeutics Inc

NASDAQ:TCRR   3:59:51 PM EDT
2.36
0.00 (0.00%)
Earnings Announcements

TCR2 Therapeutics Reports Fourth Quarter 2021 Financial Results

Published: 03/22/2022 11:41 GMT
Tcr2 Therapeutics Inc (TCRR) - Tcr² Therapeutics Reports Fourth Quarter 2021 Financial Results and Provides Corporate Update.
Expect Cash on Hand to Support Operations Into 2024.
Qtrly Net Loss per Share of Common Stock, Basic and Diluted $0.72.
Q4 Earnings per Share View $-0.75 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.78

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.